Cargando…
New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some rece...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270580/ http://dx.doi.org/10.1016/S0958-2118(20)30049-5 |
_version_ | 1783541926760284160 |
---|---|
author | Atkinson, Simon |
author_facet | Atkinson, Simon |
author_sort | Atkinson, Simon |
collection | PubMed |
description | As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some recent developments in this country, where interest in this technology continues to grow. As an aside, the company has also provided an update regarding its operations in China and how they are potentially affected by the outbreak of the coronavirus. |
format | Online Article Text |
id | pubmed-7270580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-72705802020-06-05 New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China Atkinson, Simon Membrane Technology Article As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some recent developments in this country, where interest in this technology continues to grow. As an aside, the company has also provided an update regarding its operations in China and how they are potentially affected by the outbreak of the coronavirus. 2020-03 2020-04-03 /pmc/articles/PMC7270580/ http://dx.doi.org/10.1016/S0958-2118(20)30049-5 Text en |
spellingShingle | Article Atkinson, Simon New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China |
title | New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China |
title_full | New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China |
title_fullStr | New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China |
title_full_unstemmed | New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China |
title_short | New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China |
title_sort | new strategic market segment and follow-on orders continue to strengthen aspiral's position in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270580/ http://dx.doi.org/10.1016/S0958-2118(20)30049-5 |
work_keys_str_mv | AT atkinsonsimon newstrategicmarketsegmentandfollowonorderscontinuetostrengthenaspiralspositioninchina |